虚拟现实训练对抑郁症的改善效应和机制:从神经递质-可塑性双通路的角度进行系统审查
Liang Sun1, Lanfang Luo2, Tingran Zhang1
1Physical Education Institute, Southwest University, Chongqing, China.
Journal of global health
|February 27, 2026
概括
虚拟现实 (VR) 训练通过增强神经递质平衡和神经可塑性,有望缓解抑郁症. 需要进一步的研究来优化方案,并确认这种心理健康干预的长期疗效.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 数字健康数字健康
背景情况:
- 抑郁症影响全球2.8亿人,与神经递质失衡和神经可塑性受损有关.
- 了解这些机制对于开发有效治疗方法至关重要.
研究的目的:
- 系统地评估虚拟现实 (VR) 训练对抑郁症的临床疗效.
- 探索VR的双通道调节机制,涉及神经递质-可塑性相互作用.
主要方法:
- 在四个数据库 (PubMed,科学网,CNKI,ScienceDirect) 进行系统搜索,截至2025年5月.
- 包括评估VR干预的随机对照试验 (RCT).
- 由于异质性,进行了叙事综合;使用PEDro尺度评估研究质量.
主要成果:
- 16项研究表明,通过多式感官刺激和沉浸式互动,VR训练显著减少了抑郁症状.
- 初步证据将VR疗效与神经结构恢复和功能网络同步的生物标志物联系起来.
- 协议,对照和结果的高度异质性阻止了统一的疗效估计.
结论:
- 虚拟现实训练可以通过协同神经递质调节和神经可塑性增强来逆转抑郁症的病态循环.
- 虚拟现实为精确的心理健康干预提供了一个新的策略.
- 未来的研究应该优化方案,探索组合疗法,并验证长期的安全性.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
675
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.7K
相关概念视频
Depression: Overview
1.1K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.1K
Depressive Disorders: Etiology
793
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
793
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.5K
Role of Neurotransmitters in Memory
2.7K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.7K
Antidepressant Drugs: MAOIs and Other Agents
1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
